Futura Medical Share Discussion Threads

[broomrigg] 21/4/2023 09:10

FUM on the constant gainers list.....4 days continuous gains...



Last Eroxon purchase 4 seconds ago.......



:-)

[lbo] 21/4/2023 07:55

And flexiseq another drug free class 2 medical device gel that requires to be rubbed in initially sold out but then racked up millions in losses for its shareholders! LOL

[broomrigg] 21/4/2023 07:51

Last Eroxon purchase = 28 seconds ago.Love it :-)

[dontshoutatonce] 21/4/2023 07:44

Evaporation? It goes through the skin - DERMASYS. That's one of its values and it is what the company can build on for its other items that can be adapted for loads of stuff which can only add value to this company - and how!

[glavey] 20/4/2023 23:44

Q. Why should product with no active ingredient which relies on evaporation be said to take 5-10 minutes to work?

[lbo] 20/4/2023 21:02

Even sham acupuncture can be more effective then the sham medical device Eroxon gel to stimulate ‘confidence’! And even sham acupuncture works as as as well as acupuncture! LOL



The Efficacy of Acupuncture on Patients with Erectile Dysfunction: A Review All the studies showed that acupuncture had beneficial effects on ED, with effective rates from 54% to 69%



Researchers have repeatedly shown interventions such as ‘sham’ acccupuncture to be as effective as acupuncture. Sham acupuncture uses retractable needles that do not pierce the skin



Experience has shown that while oral analgesic trials elicit some placebo response among subjects, placebo response rates tend to increase with transdermal gel

Thus, the placebo effect has become increasingly frustrating as drug companies seek to take advantage of the popularity and established safety of transdermal delivery systems.



Placebo response to manual therapy: something out of nothing

[glavey] 20/4/2023 18:24

Q. Was Eroxon trialed in the UK?

[glavey] 20/4/2023 17:57

Broomrigg
20 Apr '23 - 09:25 - 18144
"No fundraising coming folks and cash now being generated.....lots of it :-)"

Time will tell if that smiley is just a frown turned upside down.

[petroc] 20/4/2023 11:06

LiarBO getting totally frantic and distraught now! He seriously said

'ROFLMAO
So the ramper is bow claiming the ingredients in Med3000 are fermenting into something else!
Never seen bread say it contains alcohol? Or being able to sell alcohol to kids as it just has the same ingredients as Bread! LOL'

Probably the weakest defence ever when accused of stating that 'everything made with the same ingredients is the same' when shown the evidence that it isn't. Especially as all that he's doing is proving even further that things made with the same ingredients aren't the same.

ROFLMAO indeed!

[lbo] 20/4/2023 10:48

Odds are its more likely to be a Flexiseq gel! LOL

[lbo] 20/4/2023 10:48

Yes Eroxon could be an Alpecin! So could any similar gel made of alcohol, water, glycol and carbomer!!! LOL

Just like Pet500 and CSD500 could have been something but failed to sell long term even though they had more USPs and enforceable patents! Yet Reckitt still have similar products to those Futura failed products on the market! And they and GSk both walked away from MED!

If It does get De Novo medical device registration and there actually is a real market for drug free male arousal gels for psychogenic ED. It wont take long for Reckitt or competitors if they are inclined to launch a similar alcohol, water, glycol and Carbopol arousal gel product for men via the 510k pathway!

A De Novo premarket review pathway, a regulatory pathway for low- to moderate-risk devices of a new type. Along with this De Novo authorization, the FDA is establishing criteria called special controls that define the requirements related to labeling and performance testing. When met, the special controls, in combination with general controls, provide a reasonable assurance of safety and effectiveness for devices of this type. This action also creates a new regulatory classification, which means that subsequent devices of the same type with the same intended use may go through the FDA 510(k) pathway, whereby devices can obtain clearance by demonstrating substantial equivalence to a predicate device

The average length of time for clearance under the traditional 510(k) pathway is 177 days,



A company must compare their product to one already cleared by the FDA and provide evidence that their product is substantially equivalent to the previously cleared (legally marketed) device. To be substantially equivalent, the product must meet criteria for the same intended use, have the same technology or (slightly) different technology but produces similar end results, and be safe and effective. Once pre-market clearance is received from the FDA the device can be distributed commercially



Here's a startling fact: between 80% and 90% of new product launches fail, according to multiple studies including Harvard Business Review. Each year, more than 30,000 new products hit the market, from companies large and small, and year after year, history is littered with dead carcasses



Research at the Ehrenberg-Bass Institute shows new product launches can be a risky undertaking for brand owners. Investigating 83,719 new product introductions over an eight-year period, the research finds around one in four new products failed to survive one year after launch. This failure rate increased to around 40% two years after launch.



Why Most Product Launches Fail